Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Kestra Medical Technologies (KMTS) Accumulated Depreciation & Amortization (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $29.5 million as the latest value for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 78.86% to $29.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $29.5 million through Jan 2026, up 78.86% year-over-year, with the annual reading at $24.0 million for FY2025, 36.53% up from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2026 was $29.5 million at Kestra Medical Technologies, up from $27.8 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $29.5 million in Q1 2026, with the low at $16.5 million in Q1 2025.
  • Average Accumulated Depreciation & Amortization over 3 years is $23.5 million, with a median of $24.8 million recorded in 2025.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 36.53% in 2025, then soared 78.86% in 2026.
  • Over 3 years, Accumulated Depreciation & Amortization stood at $17.5 million in 2024, then surged by 58.24% to $27.8 million in 2025, then rose by 6.16% to $29.5 million in 2026.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $29.5 million, $27.8 million, and $25.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.